Temporary Denosumab Discontinuation Promotes Bone Healing of Osteonecrosis of the Jaw and Minimizes the Invasiveness of Surgery: A Case Presentation
Denosumab has proved effective at low doses in increasing bone mineral density in osteoporosis patients. In contrast to high-doses antiresorptive therapy, denosumab has a transient effect on the inhibition of the bone remodeling process, suggesting that denosumab-related osteonecrosis is a self-limi...
Saved in:
Main Authors: | Giordana Bettini (Author), Giorgia Saia (Author), Federica Benetello (Author), Alberto Bedogni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018) -
Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018) -
Posible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report
by: P. Selvi Sabater, et al.
Published: (2014) -
Case series: Osteonecrosis of the jaw related to denosumab preceded by bisphosphonates in cancer and osteoporotic patients
by: Devie Falinda, et al.
Published: (2022)